Adverse effect of mineralocorticoids and their antag, init

This code signifies an undesirable or harmful reaction experienced by a patient due to the therapeutic use of mineralocorticoids or their antagonists. These reactions are not due to an overdose or poisoning, but rather an expected, though unwanted, side effect when the medication is administered correctly. The "initial encounter" designation indicates that this is the first time the patient is being seen for this specific adverse effect.

Use this code when a patient presents with symptoms such as electrolyte imbalances (e.g., hyperkalemia, hypokalemia), hypertension, edema, or cardiac arrhythmias directly attributable to a prescribed mineralocorticoid (like fludrocortisone) or an antagonist (like spironolactone or eplerenone). This applies when the medication was taken as directed, and the adverse effect is being evaluated and treated for the first time.

• Always sequence this code after the code for the specific adverse effect (e.g., E87.5 for hyperkalemia).
• Do not use this code for poisoning, toxic effects, or underdosing; refer to the T36-T50 chapter for those scenarios.
• Ensure documentation clearly links the adverse effect to the mineralocorticoid or antagonist and specifies it as an initial encounter.